Experts recommended individualized MDD relapse prevention, including ECT tapering and pharmacotherapy based on risk profiles.

Lack of motivation is a possible depression symptom, but when it significantly affects your day-to-day activities, it may be ...

Sleep is one of the most powerful yet underutilized biomarkers in depression drug development, with objective sleep ...

Adolescent major depressive disorder represents a personal and public health challenge. Conventional drug treatments don’t ...

The use of 42 mg lumateperone combined with antidepressant therapy was linked to significantly reduced severity of depression and anxiety, as well as greater response and remission rates, and was ...

No statistically significant change in MADRS total score was observed with solriamfetol vs placebo in the overall study population. Topline results were announced from a phase 3 trial evaluating ...

In this study, researchers aimed to characterize the relationship between major depressive disorder, use of antidepressants, and risk of recurrence in breast cancer patients.

In addition to ADHD and MDD, Axsome also is investigating Sunosi as a treatment for binge eating disorder and excessive sleepiness associated with shift work disorder. Given its novel mechanism of ...

Bullfrog AI Holdings, Inc. BFRG shares are trading higher on continued strength Tuesday after the company announced a commercial agreement on Monday with a top five global pharmaceutical company to ...